Samantha Garcia

Ms. Samantha Garcia

University of California, Irvine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

24 August 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
SGSamantha Garcia
Samantha Garcia
MSMichelle Shin
Michelle Shin
KSKylie Sloan
Kylie Sloan
EDEmily Dang
Emily Dang
CGCarlos Orellana Garcia
Carlos Orellana Garcia
JTJennifer Tsui
Jennifer Tsui
The COVID-19 pandemic disrupted healthcare delivery within safety-net settings. Barriers to and facilitators of human papillomavirus (HPV) vaccination during the pandemic can inform future HPV vaccine strategies for underserved communities. Qualitative interviews (n = 52) between December 2020 and January 2022 in Los Angeles and New Jersey were conducted with providers, clinic leaders, clinic staff, advocates, payers, and policy-level representatives involved in the HPV vaccine process. Using the updated Consolidated Framework for Implementation Research we identified (1) outer setting barriers (i.e., vaccine hesitancy driven by social media, political views during the pandemic) and facilitators (e.g., partnerships); (2) inner setting clinic facilitators (i.e., motivation-driven clinic metrics, patient outreach, vaccine outreach events); (3) individual characteristics such as patient barriers (i.e., less likely to utilize clinic services during the pandemic and therefore, additional outreach to address missed vaccine doses are needed); (4) innovations in HPV vaccination strategies (i.e., clinic workflow changes to minimize exposure to COVID-19, leveraging new community partnerships (e.g., with local schools)); and (5) implementation strategies (i.e., multisectoral commitment to HPV goals). Pandemic setbacks forced safety-net settings to develop new vaccine approaches and partnerships that may translate to new implementation strategies for HPV vaccination within local contexts and communities.

SGSamantha Garcia
Samantha Garcia
SHSuellen Hopfer
Suellen Hopfer
EBElouise Botes
Elouise Botes
SGSamuel Greiff
Samuel Greiff
The coronavirus pandemic has escalated rates of anxiety in the general U.S. population. Understanding how factors associated with coronavirus anxiety at the start of the pandemic differed among populations hardest impacted by coronavirus anxiety is key to effectively remediating negatively associated health outcomes and to better understand how to address concerns of the public at the start of a global pandemic. This study was a secondary analysis of data from a cross-sectional online survey of 1165 Prolific users between 13 and 15 March 2020. Data were collected from a stratified sample of U.S. adults aged 20 or older and currently living in the United States. The sample was stratified for age, gender, and race. Coronavirus anxiety was assessed as the dependent variable, alongside three independent variables: coronavirus crisis perception, perceived economic risk of coronavirus, and general self-efficacy. Multiple linear regression assessed the associations between the independent variables and coronavirus anxiety. Interactions between independent variables and two sociodemographic variables (i.e., gender, race) were also explored. The models were adjusted for age, gender, race, education, employment, and income. The average age of participants was 45.6 ± 15.7. The majority (76%) identified as White, approximately half identified as female and reported obtaining a bachelor’s degree or higher. Coronavirus crisis perception and perceived economic risk of coronavirus were positively associated with coronavirus anxiety (β = 0.46, 95% CI = 0.41, 1.00; β = 0.14, 95% CI = 0.09, 1.00, respectively). General self-efficacy was negatively associated with coronavirus anxiety (β = −0.15, 95% CI = −1.00, −0.11). Gender and race both moderated the association between coronavirus crisis perception and anxiety. Race moderated the association between perceived economic risk and coronavirus crisis perception. These results provide a foundation to further explore cognitive factors in subgroups disproportionately affected by anxiety during the pandemic.

6 February 2025 in Annals of Epidemiology
Verified
Journal Article
Open access
ASAryana Sepassi
Aryana Sepassi
SGSamantha Garcia
Samantha Garcia
STSora Tanjasiri
Sora Tanjasiri
SLSunmin Lee
Sunmin Lee
NENana Entsuah-Boateng
Nana Entsuah-Boateng
MBMark Bounthavong
Mark Bounthavong
To investigate the association between nativity and COVID-19 vaccine acceptance and its interaction with race/ethnicity, education, and English proficiency. Differences in vaccine acceptance among propensity-score matched foreign- and US-born persons using 2021 California Health Interview Survey Data were measured using a survey-weighted multivariable logistic regression model with interaction terms and average predicted probabilities between nativity and: race/ethnicity, education, English proficiency. A total of 4,234,655 survey-weighted persons (8504 unweighted) met inclusion criteria; 2251,279 (53 %) were foreign-born (1,983,376 US-born), and 55 % of all persons were Hispanic/Latino, 22 % were Non-Hispanic White, 17 % were Non-Hispanic Asian/Pacific Islander, 3.6 % were Non-Hispanic Black/African American, and 2.5 % were categorized as 'Other'. Foreign-born status was significantly associated with greater odds of acceptance (adjusted odds ratio [aOR], 2.81 [95 %CI, 1.16-6.83]). Foreign-born Hispanic persons had a significantly greater probability of acceptance compared to their US-born counterparts (average probability difference, +0.11 [95 %CI, +0.023, +0.20]). Foreign-born persons with poor English proficiency had a lower probability of acceptance versus US-born persons (APD, -0.081, [95 %CI, -0.43, 0.27]). Nativity was significantly associated with COVID-19 vaccine acceptance, and this relationship varied by race/ethnicity and English proficiency. These findings may be used to direct future interventions aimed at improving COVID-19 vaccination rates.

16 January 2025 in Translational Behavioral Medicine
Verified
Journal Article
Closed access
SGSamantha Garcia
Samantha Garcia
STSora Park Tanjasiri
Sora Park Tanjasiri
JTJacqueline H Tran
Jacqueline H Tran
EAEllen Ahn
Ellen Ahn
SHSherry Huang
Sherry Huang
JTJennifer Tsui
Jennifer Tsui
Background: Cancer screening disparities among medically underserved Asian Americans are well documented. Assessing determinants of success in implementing multilevel cancer screening strategies in safety-net settings is critical to improve screening and cancer equity. Methods: Academic, clinic, and community partners established the Advancing Care Together (ACCT) formal network to implement multilevel strategies that promote cancer screening among low-income Chinese, Korean, and Vietnamese adults in Orange County, California. ACCT focused on breast, cervical, and colorectal cancer. From August 2018 to January 2021, meetings, surveys, and interviews were conducted with community and clinic partners before implementing evidence-based strategies (EBS) such as educational workshops and community navigation, aligned with cultural and linguistic factors, to increase cancer screening. We evaluated formative data, collected during meetings and interviews and via patient navigator intake forms, to identify barriers and facilitators to implementing EBS in Asian-serving community clinics. We assembled a code book, aligned with the exploration, preparation, implementation, and sustainment framework to guide data analysis of implementation determinants of cancer screening. Results: During the implementation of cancer screening EBS, ACCT staff and community navigators identified barriers in the inner context (lack of language-concordant providers, staff turnover) and outer context (referral wait times, transportation, and cultural stigma). Academic and community partnerships can support multilevel EBS to increase cancer screening (bridging factors). Additional support for clinic and quality improvement staff may be needed to evaluate cancer screening outcomes, and routine training on evaluating electronic medical records is needed (innovation factors). Conclusion: Community–clinic–academic partnerships can increase cancer screening and awareness in Asian American communities, including addressing cultural screening barriers and identifying adaptation needs for educational materials. Additionally, longstanding clinic- and community-level barriers persist in federally qualified health centers serving underrepresented Asian American communities. These barriers in the cancer screening process include high turnover among clinic quality improvement teams and difficulty prioritizing cancer screening throughout the COVID-19 pandemic.